BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6730415)

  • 1. [Effect of whole-body artificial hyperthermia on the immunity function in cancer patients].
    Dzhaginian AI; Balliuzek FV
    Vopr Onkol; 1984; 30(5):39-43. PubMed ID: 6730415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extracorporeally induced whole-body hyperthermia in conventionally incurable malignant tumor patients].
    Lange J; Zänker KS; Siewert JR; Eisler K; Landauer B; Kolb E; Blümel G; Remy W
    Dtsch Med Wochenschr; 1983 Mar; 108(13):504-9. PubMed ID: 6832025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase immunotherapy of tumors in man.
    Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
    Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
    [No Abstract]   [Full Text] [Related]  

  • 4. [Extracorporeal systemic hyperthermia and cis-diamminedichloroplatinum for treatment of patients with advanced cancer].
    Yokoyama M; Wada J; Nagara H; Kasagi Y; Itaoka T
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1457-61. PubMed ID: 6540070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunity state of oncological patients during long-term treatment with tramal].
    Novikov IuA; Kon'kov ShKh; Shumilov EI
    Anesteziol Reanimatol; 1994; (3):12-3. PubMed ID: 8080118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy of cancer. Experiments in the modification of tumor antigenicity].
    Mizukami T; Takamura Y
    Arch Geschwulstforsch; 1971; 37(1):33-44. PubMed ID: 4102699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Autologous tumor specific immunotherapy of refractory cancers with ex vivo-generated T cells stimulated by autologous tumor cell].
    Toh U; Yamana H; Kido K; Mine T; Fujii T; Horiuchi H; Sasatomi T; Ishibashi N; Yutani S; Fujita H; Shirouzu K
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1566-70. PubMed ID: 14619465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic function in humans before and after hyperthermia and chemotherapy for disseminated malignancy.
    DeHoratius RJ; Hosea JM; Van Epps DE; Reed WP; Edwards WS; Williams RC
    J Natl Cancer Inst; 1977 Apr; 58(4):905-11. PubMed ID: 300437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles and concept 1993 of the Systemic Cancer Multistep Therapy (sCMT). Extreme whole-body hyperthermia using the infrared-A technique IRATHERM 2000--selective thermosensitisation by hyperglycemia--circulatory back-up by adapted hyperoxemia.
    von Ardenne M
    Strahlenther Onkol; 1994 Oct; 170(10):581-9. PubMed ID: 7974169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of systemic tolerance of 42.0 degrees C infrared-A whole-body hyperthermia in combination with hyperglycemia and hyperoxemia. A Phase-I study.
    Steinhausen D; Mayer WK; von Ardenne M
    Strahlenther Onkol; 1994 Jun; 170(6):322-34. PubMed ID: 8023241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune surveillance system: its failure and activation.
    Shearer WT; Fink MP
    Prog Hematol; 1977; 10():247-310. PubMed ID: 337362
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effect of whole body hyperthermia combined with chemotherapy in patients with advanced cancer].
    Liu XL; Ma F; Zhou CX; Huang M; Gong HY; Xie GY; Hu CH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):350-2. PubMed ID: 16859121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of nonspecific factors in the therapeutic action of general hyperthermia in oncologic diseases].
    Balliuzek FV; Sokolovskiĭ VV; Dzhaginian AI; Baskovich GA; Gaĭkova ON
    Med Radiol (Mosk); 1987 May; 32(5):47-9. PubMed ID: 3586923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in hormonal-mediatory and immunological indices during anesthesia in cancer patients].
    Lian NV; Vasil'ev NV; Smol'ianinov ES; Kuznetsov VV
    Vopr Onkol; 1986; 32(10):54-8. PubMed ID: 2877523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocompetence testing in patients with one of the four common operable cancers--a review.
    Wanebo HJ; Pinsky CM; Beattie EJ; Oettgen HF
    Clin Bull; 1978; 8(1):15-22. PubMed ID: 668106
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of whole-body controlled hyperthermia on the energy resources of cancer patients].
    Prokhorova VI; Zhavrid EA; Fradkin SZ; Rubanova VZ; Lappo SV; Tsyrus' TP
    Vopr Onkol; 1991; 37(11-12):1050-4. PubMed ID: 1669196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies to thyroglobulin in patients with cancer].
    Bershteĭn LM; Golubev VN; L'vovich EG; Dil'man VM
    Vopr Onkol; 1977; 23(5):14-8. PubMed ID: 888413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthermia and immunity. A brief overview.
    Baronzio G; Gramaglia A; Fiorentini G
    In Vivo; 2006; 20(6A):689-95. PubMed ID: 17203747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Addition of hyperthermia. Heat potentiates cancer therapy].
    Hegewisch-Becker S; Hossfeld DK
    MMW Fortschr Med; 2001 Jun; 143(25):28-32. PubMed ID: 11468993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and physiological responses to whole-body hyperthermia.
    Bull JM; Lees DE; Schuette WH; Smith R; Glatstein E; DeVita VT
    Natl Cancer Inst Monogr; 1982 Jun; 61():177-81. PubMed ID: 7177176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.